J.P. Morgan Partners, affiliates, sell some 2 million shares of Seattle Genetics Stock

By Lisa Kerner

Charlotte, N.C., March 1 - J.P. Morgan Partners (BHCA), LP and its affiliates sold 2,015,000 shares of Seattle Genetics, Inc. common stock in open market transactions on Feb. 9 at a price of $8.57 per share, according to a schedule 13D filing with the Securities and Exchange Commission.

Collectively, J.P. Morgan Partners (BHCA) and the global fund entities own 5,317,500 shares, or 10.42%, of the Bothell, Wash.-based biotechnology company's common stock.

Seattle Genetics' stock (Nasdaq: SGEN) closed at $7.80 on Feb. 28.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.